{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:12:51Z","timestamp":1707523971404},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,27]]},"DOI":"10.7759\/cureus.19952","type":"journal-article","created":{"date-parts":[[2021,11,28]],"date-time":"2021-11-28T07:25:08Z","timestamp":1638084308000},"source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Outcomes of Collagenase Clostridium Histolyticum Injection for Palmar Dupuytren\u2019s Deformity Correction"],"prefix":"10.7759","author":[{"given":"Sarang","family":"Kasture","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Sakamuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2106\/00004623-200701000-00026","article-title":"Dupuytren disease: Anatomy, pathology, presentation, and treatment","volume":"89","author":"Rayan GM","year":"2007","unstructured":"Rayan GM. Dupuytren disease: Anatomy, pathology, presentation, and treatment. J Bone Joint Surg Am. 2007, 89:189-98. 10.2106\/00004623-200701000-00026","journal-title":"J Bone Joint Surg Am"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1097\/01.PRS.0000146039.21330.CE","article-title":"Identification of a novel mitochondrial mutation in Dupuytren's disease using multiplex DHPLC","volume":"115","author":"Bayat A","year":"2005","unstructured":"Bayat A, Walter J, Lambe H, et al.. Identification of a novel mitochondrial mutation in Dupuytren's disease using multiplex DHPLC. Plast Reconstr Surg. 2005, 115:134-41.","journal-title":"Plast Reconstr Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11552-009-9255-y","article-title":"Role of the HLA System in the Pathogenesis of Dupuytren's Disease","volume":"5","author":"McCarty S","year":"2010","unstructured":"McCarty S, Syed F, Bayat A. Role of the HLA System in the Pathogenesis of Dupuytren's Disease. Hand (N Y). 2010, 5:241-50. 10.1007\/s11552-009-9255-y","journal-title":"Hand (N Y)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1101029","article-title":"Wnt signaling and Dupuytren's disease","volume":"365","author":"Dolmans GH","year":"2011","unstructured":"Dolmans GH, Werker PM, Hennies HC, et al.. Wnt signaling and Dupuytren's disease. N Engl J Med. 2011, 365:307-17. 10.1056\/NEJMoa1101029","journal-title":"N Engl J Med"},{"key":"ref5","article-title":"Percutaneous needle fasciotomy in Dupuytren's contracture: is it a viable technique?","volume":"78","author":"Pereira A","year":"2012","unstructured":"Pereira A, Massada M, Sousa R, Silva C, Trigueiros M, Lemos R. Percutaneous needle fasciotomy in Dupuytren's contracture: is it a viable technique?. Acta Orthop Belg. 2012, 78:30-4.","journal-title":"Acta Orthop Belg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e31823aea95","article-title":"Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy","volume":"129","author":"van Rijssen AL","year":"2012","unstructured":"van Rijssen AL, Ter Linden H, Werker PM. Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy. Plast Reconstr Surg. 2012, 129:469-77. 10.1097\/PRS.0b013e31823aea95","journal-title":"Plast Reconstr Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0072-968x(71)90010-6","article-title":"Enzymic fasciotomy","volume":"3","author":"Hueston JT","year":"1971","unstructured":"Hueston JT. Enzymic fasciotomy. Hand. 1971, 3:38-40. 10.1016\/0072-968x(71)90010-6","journal-title":"Hand"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0363-5023(96)80368-6","article-title":"Collagenase in the treatment of Dupuytren's disease: an in vitro study","volume":"21","author":"Starkweather KD","year":"1996","unstructured":"Starkweather KD, Lattuga S, Hurst LC, et al.. Collagenase in the treatment of Dupuytren's disease: an in vitro study. J Hand Surg Am. 1996, 21:490-5. 10.1016\/S0363-5023(96)80368-6","journal-title":"J Hand Surg Am"},{"key":"ref9","unstructured":"Briefing document for collagenase clostridium histolyticum (AA4500) in the treatment of advanced Dupuytren's disease. (2009). https.\/\/www.sec.gov\/Archives\/edgar\/data\/1182129\/000119312509191187\/dex991.htm."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810866","article-title":"Injectable collagenase clostridium histolyticum for Dupuytren's contracture","volume":"361","author":"Hurst LC","year":"2009","unstructured":"Hurst LC, Badalamente MA, Hentz VR, et al.. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Engl J Med. 2009, 361:968-79. 10.1056\/NEJMoa0810866","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2010.08.007","article-title":"Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease","volume":"35","author":"Gilpin D","year":"2010","unstructured":"Gilpin D, Coleman S, Hall S, Houston A, Karrasch J, Jones N. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease. J Hand Surg Am. 2010, 35:2027-38.e1. 10.1016\/j.jhsa.2010.08.007","journal-title":"J Hand Surg Am"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2012.10.008","article-title":"Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies","volume":"38","author":"Witthaut J","year":"2013","unstructured":"Witthaut J, Jones G, Skrepnik N, Kushner H, Houston A, Lindau TR. Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies. J Hand Surg Am. 2013, 38:2-11. 10.1016\/j.jhsa.2012.10.008","journal-title":"J Hand Surg Am"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.hansur.2017.06.007","article-title":"Efficacy and safety of collagenase treatment for Dupuytren's disease: 2-year follow-up results","volume":"36","author":"Van Beeck A","year":"2017","unstructured":"Van Beeck A, Van den Broek M, Michielsen M, Didden K, Vuylsteke K, Verstreken F. Efficacy and safety of collagenase treatment for Dupuytren's disease: 2-year follow-up results. Hand Surg Rehabil. 2017, 36:346-9. 10.1016\/j.hansur.2017.06.007","journal-title":"Hand Surg Rehabil"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldw020","article-title":"Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review","volume":"118","author":"Smeraglia F","year":"2016","unstructured":"Smeraglia F, Del Buono A, Maffulli N. Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review. Br Med Bull. 2016, 118:149-58. 10.1093\/bmb\/ldw020","journal-title":"Br Med Bull"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-014-1111-6","article-title":"Early results of the use of collagenase in the treatment of Dupuytren's contracture","volume":"184","author":"Considine S","year":"2015","unstructured":"Considine S, Heaney R, Hirpara KM. Early results of the use of collagenase in the treatment of Dupuytren's contracture. Ir J Med Sci. 2015, 184:323-7. 10.1007\/s11845-014-1111-6","journal-title":"Ir J Med Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jos.2018.10.015","article-title":"Short-term efficacy and safety of collagenase injection for Dupuytren's contracture: Therapy protocol for successful outcomes in a clinical setting","volume":"24","author":"Sakai A","year":"2019","unstructured":"Sakai A, Zenke Y, Menuki K, Yamanaka Y, Tajima T, Tsukamoto M, Uchida S. Short-term efficacy and safety of collagenase injection for Dupuytren's contracture: Therapy protocol for successful outcomes in a clinical setting. J Orthop Sci. 2019, 24:434-40. 10.1016\/j.jos.2018.10.015","journal-title":"J Orthop Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1142\/S0218810415500288","article-title":"Comparison between collagenase injection and partial fasciectomy in the treatment of Dupuytren's contracture","volume":"20","author":"Tay TK","year":"2015","unstructured":"Tay TK, Tien H, Lim EY. Comparison between collagenase injection and partial fasciectomy in the treatment of Dupuytren's contracture. Hand Surg. 2015, 20:386-90. 10.1142\/S0218810415500288","journal-title":"Hand Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2007.04.002","article-title":"Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture","volume":"32","author":"Badalamente MA","year":"2007","unstructured":"Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg Am. 2007, 32:767-74. 10.1016\/j.jhsa.2007.04.002","journal-title":"J Hand Surg Am"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012943","article-title":"Collagenase injections for Dupuytren's disease: prospective cohort study assessing 2-year treatment effect durability","volume":"7","author":"Lauritzson A","year":"2017","unstructured":"Lauritzson A, Atroshi I. Collagenase injections for Dupuytren's disease: prospective cohort study assessing 2-year treatment effect durability. BMJ Open. 2017, 7:e012943. 10.1136\/bmjopen-2016-012943","journal-title":"BMJ Open"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/1753193415597421","article-title":"A single injection of collagenase clostridium histolyticum for the treatment of moderate Dupuytren's contracture: a 2\u2009year follow-up of 47 patients","volume":"41","author":"McFarlane J","year":"2016","unstructured":"McFarlane J, Syed AM, Sibly TF. A single injection of collagenase clostridium histolyticum for the treatment of moderate Dupuytren's contracture: a 2\u2009year follow-up of 47 patients. J Hand Surg Eur Vol. 2016, 41:664-5. 10.1177\/1753193415597421","journal-title":"J Hand Surg Eur Vol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2012.09.028","article-title":"Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data","volume":"38","author":"Peimer CA","year":"2013","unstructured":"Peimer CA, Blazar P, Coleman S, et al.. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data. J Hand Surg Am. 2013, 38:12-22. 10.1016\/j.jhsa.2012.09.028","journal-title":"J Hand Surg Am"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-013-0139-0","article-title":"Isolated and spontaneous correction of proximal interphalangeal joint contractures in Dupuytren's disease: an exploratory analysis of the efficacy and safety of collagenase Clostridium histolyticum","volume":"33","author":"Hayton MJ","year":"2013","unstructured":"Hayton MJ, Bayat A, Chapman DS, Gerber RA, Szczypa PP. Isolated and spontaneous correction of proximal interphalangeal joint contractures in Dupuytren's disease: an exploratory analysis of the efficacy and safety of collagenase Clostridium histolyticum. Clin Drug Investig. 2013, 33:905-12. 10.1007\/s40261-013-0139-0","journal-title":"Clin Drug Investig"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2015.06.099","article-title":"The efficacy and safety of concurrent collagenase clostridium histolyticum injections for 2 Dupuytren contractures in the same hand: a prospective, multicenter study","volume":"40","author":"Gaston RG","year":"2015","unstructured":"Gaston RG, Larsen SE, Pess GM, et al.. The efficacy and safety of concurrent collagenase clostridium histolyticum injections for 2 Dupuytren contractures in the same hand: a prospective, multicenter study. J Hand Surg Am. 2015, 40:1963-71. 10.1016\/j.jhsa.2015.06.099","journal-title":"J Hand Surg Am"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2015.04.036","article-title":"Dupuytren contracture recurrence following treatment with Collagenase Clostridium histolyticum (CORDLESS Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study): 5-Year data","volume":"40","author":"Peimer CA","year":"2015","unstructured":"Peimer CA, Blazar P, Coleman S, Kaplan FT, Smith T, Lindau T. Dupuytren contracture recurrence following treatment with Collagenase Clostridium histolyticum (CORDLESS Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study): 5-Year data. J Hand Surg Am. 2015, 40:1597-605. 10.1016\/j.jhsa.2015.04.036","journal-title":"J Hand Surg Am"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2010.01.003","article-title":"Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up","volume":"35","author":"Watt AJ","year":"2010","unstructured":"Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up. J Hand Surg Am. 2010, 35:534-9, 539.e1. 10.1016\/j.jhsa.2010.01.003","journal-title":"J Hand Surg Am"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s11552-013-9540-7","article-title":"Functional outcome of collagenase injections compared with fasciectomy in treatment of Dupuytren's contracture","volume":"8","author":"Naam NH","year":"2013","unstructured":"Naam NH. Functional outcome of collagenase injections compared with fasciectomy in treatment of Dupuytren's contracture. Hand (N Y). 2013, 8:410-6. 10.1007\/s11552-013-9540-7","journal-title":"Hand (N Y)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2013.10.002","article-title":"Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures","volume":"39","author":"Coleman S","year":"2014","unstructured":"Coleman S, Gilpin D, Kaplan FT, et al.. Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures. J Hand Surg Am. 2014, 39:57-64. 10.1016\/j.jhsa.2013.10.002","journal-title":"J Hand Surg Am"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L","article-title":"Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG)","volume":"29","author":"Hudak PL","year":"1996","unstructured":"Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG). Am J Ind Med. 1996, 29:602-8. 10.1002\/(SICI)1097-0274(199606)29:6&lt;602::AID-AJIM4&gt;3.0.CO;2-L","journal-title":"Am J Ind Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/76917-long-term-outcomes-of-collagenase-clostridium-histolyticum-injection-for-palmar-dupuytrens-deformity-correction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:01Z","timestamp":1707507001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/76917-long-term-outcomes-of-collagenase-clostridium-histolyticum-injection-for-palmar-dupuytrens-deformity-correction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,27]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.19952","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,27]]}}}